Skip to main content

Table 4 Analysis for time to fourth injection during follow-up in Cox regression

From: Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial

Variable

HR

95%CI

P value

Group (ref = 1)

 Group = 2

1.43

(0.75, 2.76)

0.2797

BCVA at baseline

0.98

(0.95, 1.02)

0.3330

  1. BCVA best corrected visual acuity
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us